Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > Biden Admin supports manufacturing of at home 15 m test
View:
Post by nodeals on Feb 01, 2021 4:22pm

Biden Admin supports manufacturing of at home 15 m test

New that 230 million in funding for Austrailian manufacturing of at home testing in USA  the company is "Alune"  and the cost $30 

Can't be long before SONA gets support/sales. Forget HC , they have not been helpful to now. bureaucratic !

heard this on NPR hourly news
Comment by nodeals on Feb 01, 2021 5:57pm
The name is Ellune, FDA approval Dec 15 2020. they must have been a "priority" 
Comment by TheeRook on Feb 01, 2021 6:45pm
SONA through  in the towel for the US. .  Can't beat $5. HHS has allocated $300 million for the purchase of an additional 60 million Abbott BinaxNOW Ag Card rapid tests or "equivalent" point-of-care COVID-19 testing technology, as the U.S. set a new daily record for the number of coronavirus-related deaths on Thursday.   Giroir also ...more  
Comment by MikeyH on Feb 02, 2021 6:25am
Seriously, just forget North America - SONA failed in both Canada and the USA, they have no chance in either now... that ship has sailed. Europe is the last hope. Huge market, but masses of competition with many others holding individual country regulatory approval. Failure to secure meaningful sales equals game over for SONA. This is the dictionary definition of a one trick pony, and if they can ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities